Theseus Pharmaceuticals, Inc.
THRX · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $191,681 | $454,843 | $471,327 | $471,327 |
| - Cash | $94,605 | $244,662 | $8,457 | $1,317 |
| + Debt | $3,979 | $0 | $0 | $0 |
| Enterprise Value | $101,055 | $210,181 | $462,870 | $470,010 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$438 | -$2 | -$2 | -$2 |
| % Margin | – | – | – | – |
| EBITDA | -$54,086 | -$27,334 | -$6,834 | -$4,940 |
| % Margin | – | – | – | – |
| Net Income | -$47,080 | -$27,308 | -$11,997 | -$7,183 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.22 | -0.76 | -0.47 | -0.28 |
| % Growth | -60.5% | -61.7% | -67.9% | – |
| Operating Cash Flow | -$32,945 | -$27,193 | -$4,852 | -$4,807 |
| Capital Expenditures | -$455 | $12 | $0 | $0 |
| Free Cash Flow | -$33,400 | -$27,181 | -$4,852 | -$4,807 |